to home Nagoya City University Dept of Psychiatry,Nagoya City Univ Graduate School of Medical Sciences by Division of Psychiatry and Cognitive-Behavioral Medicine and Division of  Psycho-Oncology

Mood disorders

  • Watanabe N, Furukawa TA, Shimodera S, Morokuma I, Katsuki F, Fujita H, Sasaki M, Kawamura C & Perlis ML (in press) Brief behavioral therapy for refractory insomnia in residual depression: Assessor-blind, randomized controlled trial. Journal of Clinical Psychiatry.
  • Furukawa TA, Azuma H, Takeuchi H, Kitamura T & Takahashi K (in press) 10-year course of social adjustment in major depression. International Journal of Social Psychiatry.
  • Kojima M, Hayano J, Suzuki S, Seno H, Kasuga H, Takahashi H, Toriyama T, Kawahara H & Furukawa TA (in press) Depression, alexythymia and long-term mortality in chronic hemodialysis patients. Psychotherapy and Psychosomatics.
  • Furukawa TA (in press) Assessment of mood: Guides for clinicians. Journal of Psychosomatic Research.
  • Saito M, Iwata N, Kawakami N, Matsuyama Y, Ono Y, Nakane Y, Nakamura Y, Tachimori H, Uda H, Nakane H, Watanabe M, Naganuma Y, Furukawa TA, Hata Y, Kobayashi M, Miyake Y, Takeshima T & Kikkawa T (in prress) Evaluation of the DSM-IV and ICD-10 criteria for depresssive disorders in a community population in Japan using item response theory. International Journal of Methods in Psychiatric Research.
  • Furukawa TA, Watanabe N & Omori IM (in press) What (no) differences in response to three classes of psychotropics can teach us about distinctions between GAD and MDD. In Diagnostic Issues in Depression and Generalized Anxiety Disorder: Refining the Research Agenda for DSM-V. (eds Goldberg D, Kendler KS, Sirovatka P & Regier DA). Arlington, VA: American Psychiatric Association.
  • Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R & Furukawa TA (2010) Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis. CNS Drugs, 24, 35-53.
  • Azuma H, Segawa K, Nakaaki S, Murata Y, Kawakami K, Tohyama J, Iidaka T, Shinagawa Y, Nakano Y, Yamada A, Watanabe N, Hongo J, Akechi T & Furukawa TA (2009) Neural correlates of memory in depression measured by brain perfusion SPECT at rest. Psychiatry and Clinical Neurosciences, 63, 685-692.
  • Omori IM, Watanabe N, Nakagawa A, Akechi T, Cipriani A, Barbui C, McGuire H, Churchill R & Furukawa TA (2009) Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis. Journal of Psychopharmacoogy, 23, 539-550.
  • Barbui C, Cipriani A, Furukawa TA, Salanti G, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM & Geddes JR (2009) Making the best use of available evidence: the case of new generation atidepressants. A response to: Are all antidepressants equal? Evidence-Based Mental Health, 12, 101-104.
  • Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R & Furukawa TA (2009) Milnacipran versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews, CD006529.
  • Akechi T, Ietsugu T, Sukigara M, Okamura H, Nakano T, Akizuki N, Okamura M, Shimizu K, Okuyama T, Furukawa TA & Uchitomi Y (2009) Symptom indicator of severity of depression in cancer patients: a comparison of the DSM-IV criteria with alternative diagnostic criteria. General Hospital Psychiatry, 31, 225-232.
  • Cipriani, A., La Ferla, T., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R., McGuire, H. & Barbui, C. (2009) Sertraline versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews, CD006117.
  • Cipriani, A., Santilli, C., Furukawa, T. A., Signoretti, A., Nakagawa, A., McGuire, H., Churchill, R. & Barbui, C. (2009) Escitalopram versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews, CD006532.
  • Furukawa TA, Yoshimura R, Harai H, Imaizumi T, Takeuchi H, Kitamura T & Takahashi K (2009) How many well vs. unwell days can you expect over 10 years, once you become depressed? Acta Psychiatrica Scandinavica, 119, 290-297.
  • Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M & Barbui C (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet, 373, 746-758.
  • Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R & Furukawa TA (2008) Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: Systematic review and meta-analysis. Journal of Clinical Psychiatry, 69, 1404-1415.
  • Ono Y, Kawakami N, Nakane Y, Nakamura Y, Tachimori H, Iwata N, Uda H, Nakane H, Watanabe M, Naganuma Y, Furukawa TA, Hata Y, Kobayashi M, Miyake Y, Tajima M, Takeshima T & Kikkawa T (2008) Prevalence of and risk factors for suicide-related outcomes in the World Health Organization World Mental Health Surveys Japan. Psychiatry and Clinical Neurosciences, 62, 442-449.
  • Cipriani A, Furukawa TA, Geddes JR, Malvini L, Signoretti A, McGuire H, Churchill R, Nakagawa A & Barbui C (2008) Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis. Journal of Clinical Psychiatry, 69, 1732-1742.
  • Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R & Furukawa TA (2008) Efficacy and Tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : A systematic review and meta-analysis. CNS Drugs, 22, 587-602.
  • Kojima M, Hayano J, Fukuta H, Sakata S, Mukai S, Ohte N, Seno H, Toriyama T, Kawahara H, Furukawa TA & Tokudome S (2008) Loss of fractal heart rate dynamics in depressive hemodialysis patients. Psychosomatic Medicine, 70, 177-185.
  • Furukawa TA, Fujita A, Harai H, Yoshimura R, Kitamura T & Takahashi K (2008) Definitions of recovery and outcomes of major depression: results from a 10-year follow-up. Acta Psychiatrica Scandinavica, 117, 35-40.
  • Fujita A, Azuma H, Kitamura T, Takahasi K, Akechi T & Furukawa TA (2008) Adequacy of continuation and maintenance treatments for major depression in Japan. Journal of Psychopharmacology, 22, 153-156.
  • Barbui C, Furukawa TA & Cipriani A (2008) Effectiveness of serotonin reuptake inhibitors. Canadian Medical Association Journal, 178, 1185-1186.
  • Barbui C, Furukawa TA & Cipriani A (2008) Effectiveness of paroxetine in the acute phase treatment of adults with major depression: a systematic re-examination of published and unpublished randomised data. Canadian Medical Association Journal, 178, 296-305.
  • Watanabe N, Hunot V, Omori IM, Churchill R & Furukawa TA (2007) Psychotherapy for depression among children and adolescents: a systematic review. Acta Psychiatrica Scandinavica, 116, 84-95.
  • Tabuse H, Kalali A, Azuma H, Ozaki N, Iwata N, Naitoh H, Higuchi T, Kanba S, Shioe K, Akechi T & Furukawa TA (2007) The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training. Psychiatry Research, 153, 61-67.
  • Okuyama T, Nakane Y, Endo C, Seto T, Kato M, Seki N, Akechi T, Furukawa TA, Eguchi K & Hosaka T (2007) Mental health literacy in Japanese cancer patients: ability to recognize depression and preferences of treatments-comparison with Japanese lay public. Psycho-Oncology, 16, 834-842.
  • Kojima M, Hayano J, Tokudome S, Suzuki S, Ibuki K, Tomizawa H, Nakata A, Seno H, Toriyama T, Kawahara H & Furukawa TA (2007) Independent associations of alexithymia and social support with depression in hemodialysis patients. Journal of Psychosomatic Research, 63, 349-356.
  • Geddes JR, Furukawa TA, Cipriani A & Barbui C (2007) Depressive disorder needs an evidence base commensurate with its public health importance. Canadian Journal of Psychiatry, 52, 543-544.
  • Cipriani A, Geddes JR, Furukawa TA & Barbui C (2007) Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice. Canadian Journal of Psychiatry, 52, 553-562.
  • Furukawa TA, Cipriani A, Barbui C & Geddes JR (2007) Long-term treatment of depression with antidepressants: A systematic narrative review. Canadian Journal of Psychiatry, 52, 545-552.
  • Furukawa TA, Akechi T, Azuma H, Okuyama T & Higuchi T (2007) Evidence-based guidelines for interpretation of the Hamilton Rating Scale for Depression. Journal of Clinical Psychopharmacology, 27, 531-534.
  • Cipriani A, Malvini L, Furukawa TA & Barbui C (2007) Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates: Systematic review, meta-analysis, and meta-regression analysis. Journal of Clinical Psychopharmacology, 27, 352-356.
  • Azuma H, Fujita A, Sato K, Arahata K, Otsuki K, Hori M, Mochida Y, Uchida M, Yamada T, Akechi T & Furukawa TA (2007) Postictal cardiovascular response predicts therapeutic efficacy of electroconvulsive therapy for depression. Psychiatry and Clinical Neurosciences, 61, 290-294.
  • Azuma H, Fujita A, Sato K, Arahata K, Otsuki K, Hori M, Mochida Y, Uchida M, Yamada T, Akechi T & Furukawa TA (2007) Postictal suppression correlates with therapeutic efficacy for depression in bilateral sine and pulse wave electroconvulsive therapy. Psychiatry and Clinical Neurosciences, 61, 168-173.
  • Azuma H, Fujita A, Otsuki K, Nakano Y, Kamao T, Nakamura C, Fujioi J, Otake H, Nishigaki M, Suzuki M, Kataoka M, Matsuzawa T, Sonoda M, Nakaaki S, Murata Y, Akechi T & Furukawa TA (2007) Ictal electroencephalographic correlates of posttreatment neuropsychological changes in electroconvulsive therapy: a hypothesis-generation study. Journal of ECT, 23, 163-168.
  • Akechi T, Iwasaki M, Uchitomi Y & Tsugane S (2006) Alcohol consumption and suicide among middle-aged men in Japan. British Journal of Psychiatry, 188, 231-236.
  • Akechi T, Okuyama T, Sugawara Y, Shima Y, Furukawa TA & Uchitomi Y (2006) Screening for depression in terminally ill cancer patients in Japan. Journal of Pain and Symptom Management, 31, 5-12.
  • Cipriani A, Barbui C, Brambilla P, Furukawa T, Hotopf M & Geddes J (2006) Are all antidepressants really the same? The case of fluoxetine: a systematic review. Journal of Clinical Psychiatry, 67, 850-864.
  • Fujita A, Nakaaki S, Segawa K, Azuma H, Sato K, Arahata K, Otsuki K, Hori M, Mochida Y, Uchida M, Yamada T, Nakamura C, Akechi T & Furukawa TA (2006) Memory, attention, and executive functions before and after sine and pulse wave electroconvulsive therapies for treatment-resistant major depression. Journal of ECT, 22, 107-112.
  • Furukawa TA, Streiner DL, Young LT & Kinoshita Y (2006) Antidepressants plus benzodiazepine for major depression. Cochrane Database of Systematic Reviews.
  • Kitamura T, Yoshida K, Okano T, Kinoshita K, Hayashi M, Toyoda N, Ito M, Kudo N, Tada K, Kanazawa K, Sakumoto K, Satoh S, Furukawa T & Nakano H (2006) Multicentre prospective study of perinatal depression in Japan: incidence and correlates of antenatal and postnatal depression. Archives of Women's Mental Health, 9, 121-130.
  • Okumura K & Furukawa TA (2006) Remission rates of milnacipran 100 mg/day and 150 mg/day in the long-term treatment of major depression. Clinical Drug Investigation, 26, 135-142.
  • Segawa K, Azuma H, Sato K, Yasuda T, Arahata K, Otsuki K, Tohyama J, Soma T, Iidaka T, Nakaaki S & Furukawa TA (2006) Regional cerebral blood flow changes in depression after electroconvulsive therapy. Psychiatry Research, 147, 135-143.
  • Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, Malvini L & Barbui C (2005) Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database of Systematic Reviews, 4, CD004185.
  • Furukawa TA, Streiner DL, Azuma H, Higuchi T, Kamijima K, Kanba S, Ozaki N, Aoba A, Murasaki M & Miura S (2005) Cross-cultural equivalence in depression assessment: Japan-Europe-North American study. Acta Psychiatrica Scandinavica, 112, 279-285.
  • Hiroe T, Kojima M, Yamamoto I, Nojima S, Kinoshita Y, Hashimoto N, Watanabe N, Maeda T & Furukawa TA (2005) Gradations of clinical severity and sensitivity to change assessed with the Beck Depression Inventory-II in Japanese patients with depression. Psychiatry Research, 135, 229-235.
  • Akechi T, Okuyama T, Sugawara Y, Nakano T, Shima Y & Uchitomi Y (2004) Suicidality in terminally ill Japanese patients with cancer. Cancer, 100, 183-191.
  • Akechi T, Okuyama T, Sugawara Y, Nakano T, Shima Y & Uchitomi Y (2004) Major depression, adjustment disorders, and post-traumatic stress disorder in terminally ill cancer patients: associated and predictive factors. Journal of Clinical Oncology, 22, 1957-1965.
  • Akechi T, Nakano T, Akizuki N, Okamura M, Sakuma K, Nakanishi T, Yoshikawa E & Uchitomi Y (2003) Somatic symptoms for diagnosing major depression in cancer patients. Psychosomatics, 44, 244-248.
  • Akizuki N, Akechi T, Nakanishi T, Yoshikawa E, Okamura M, Nakano T, Murakami Y & Uchitomi Y (2003) Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer, 97, 2605-2613.
  • Furukawa T, McGuire H & Barbui C (2003) Low dosage tricyclic antidepressants for depression. Cochrane Database of Systematic Reviews, CD003197.
  • Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E & Goodwin GM (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet, 361, 653-661.
  • Kanai T, Takeuchi H, Furukawa TA, Yoshimura R, Imaizumi T, Kitamura T & Takahashi K (2003) Time to recurrence after recovery from major depressive episodes and its predictors. Psychological Medicine, 33, 839-845.
  • Kojima M, Senda Y, Nagaya T, Tokudome S & Furukawa TA (2003) Alexithymia, depression and social support among Japanese workers. Psychotherapy and Psychosomatics, 72, 307-314.
  • Takeuchi H, Hiroe T, Kanai T, Morinobu S, Kitamura T, Takahashi K & Furukawa TA (2003) Childhood parental separation experiences and depressive symptomatology in acute major depression. Psychiatry and Clinical Neurosciences, 57, 215-219.
  • Uchitomi Y, Mikami I, Nagai K, Nishiwaki Y, Akechi T & Okamura H (2003) Depression and psychological distress in patients during the year after curative resection of non-small-cell lung cancer. Journal of Clinical Oncology, 21, 69-77.
  • Yamada K, Nagayama H, Tsutiyama K, Kitamura T & Furukawa T (2003) Coping behavior in depressed patients: a longitudinal study. Psychiatry Research, 121, 169-177.
  • Akechi T, Nakano T, Akizuki N, Nakanishi T, Yoshikawa E, Okamura H & Uchitomi Y (2002) Clinical factors associated with suicidality in cancer patients. Japanese Journal of Clinical Oncology, 32, 506-511.
  • Akechi T, Okamura H, Nishiwaki Y & Uchitomi Y (2002) Predictive factors for suicidal ideation in patients with unresectable lung carcinoma. Cancer, 95, 1085-1093.
  • Furukawa TA (2002) Overview of recent research on premorbid personality of mood disorders in Japan. In Recent Advances in the Research of Affective Disorders in Japan. (eds Okuma T, Kanba S & Inoue Y), pp. 23-35. Tokyo: Elsevier.
  • Furukawa TA, McGuire H & Barbui C (2002) Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review. BMJ, 325, 991-995.
  • Furukawa TA, Streiner DL & Young LT (2002) Antidepressant and benzodiazepine for major depression. Cochrane Database of Systematic Reviews, CD001026.
  • Kojima M, Furukawa TA, Takahashi H, Kawai M, Nagaya T & Tokudome S (2002) Cross-cultural validation of the Beck Depression Inventory-II in Japan. Psychiatry Research, 110, 291-299.
  • Sugiura-Ogasawara M, Furukawa TA, Nakano Y, Hori S, Aoki K & Kitamura T (2002) Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters. Human Reproduction, 17, 2580-2584.
  • Akechi T, Okamura H, Yamawaki S & Uchitomi Y (2001) Why do some cancer patients with depression desire an early death and others do not? Psychosomatics, 42, 141-145.
  • Furukawa TA (2001) Prognosis of depression and generalised anxiety in primary care. British Journal of Psychiatry, 179, 177-178.
  • Furukawa TA, Streiner DL & Young LT (2001) Is antidepressant-benzodiazepine combination therapy clinically more useful? A meta-analytic study. Journal of Affective Disorders, 65, 173-177.
  • Furukawa TA, Streiner DL & Young LT (2001) Antidepressant plus benzodiazepine for major depression. Cochrane Database of Systematic Reviews, CD001026.
  • Furukawa TA, Takeuchi H, Hiroe T, Mashiko H, Kamei K, Kitamura T & Takahashi K (2001) Symptomatic recovery and social functioning in major depression. Acta Psychiatrica Scandinavica, 103, 257-261.
  • Ito S, Takeuchi H & Furukawa TA (2001) Cognitive therapy and social functioning in chronic depression. British Journal of Psychiatry, 178, 477-478.
  • Akechi T, Okamura H, Kugaya A, Nakano T, Nakanishi T, Akizuki N, Yamawaki S & Uchitomi Y (2000) Suicidal ideation in cancer patients with major depression. Japanese Journal of Clinical Oncology, 30, 221-224.
  • Furukawa T, Streiner DL & Young LT (2000) Antidepressant plus benzodiazepine for major depression. Cochrane Database of Systematic Reviews, CD001026.
  • Furukawa TA, Kitamura T & Takahashi K (2000) Treatment received by depressed patients in Japan and its determinants: naturalistic observation from a multi-center collaborative follow-up study. Journal of Affective Disorders, 60, 173-179.
  • Furukawa TA, Kitamura T & Takahashi K (2000) Time to recovery of an inception cohort with hitherto untreated unipolar major depressive episodes. British Journal of Psychiatry, 177, 331-335.
  • Furukawa TA, Konno W, Morinobu S, Harai H, Kitamura T & Takahashi K (2000) Course and outcome of depressive episodes: comparison between bipolar, unipolar and subthreshold depression. Psychiatry Research, 96, 211-220.
  • Uchitomi Y, Mikami I, Kugaya A, Akizuki N, Nagai K, Nishiwaki Y, Akechi T & Okamura H (2000) Depression after successful treatment for nonsmall cell lung carcinoma. Cancer, 89, 1172-1179.
  • Akechi T, Kugaya A, Okamura H, Nakano T, Okuyama T, Mikami I, Shima Y, Yamawaki S & Uchitomi Y (1999) Suicidal thoughts in cancer patients: clinical experience in psycho-oncology. Psychiatry and Clinical Neurosciences, 53, 569-573.
  • Furukawa TA, Anraku K, Hiroe T, Takahashi K, Yoshimura R, Hirai T, Kitamura T & Takahashi K (1999) A polydiagnostic study of depressive disorders according to DSM-IV and 23 classical diagnostic systems. Psychiatry and Clinical Neurosciences, 53, 387-396.
  • Furukawa TA, Ogura A, Hirai T, Fujihara S, Kitamura T & Takahashi K (1999) Early parental separation experiences among patients with bipolar disorder and major depression: a case-control study. Journal of Affective Disorders, 52, 85-91.
  • Kugaya A, Akechi T, Nakano T, Okamura H, Shima Y & Uchitomi Y (1999) Successful antidepressant treatment for five terminally ill cancer patients with major depression, suicidal ideation and a desire for death. Supportive Care in Cancer, 7, 432-436.
  • Kugaya A, Akechi T, Okamura H, Mikami I & Uchitomi Y (1999) Correlates of depressed mood in ambulatory head and neck cancer patients. Psycho-Oncology, 8, 494-499.
  • Nakano T, Kugaya A, Akechi T, Mikami I, Okuyama T, Okamura H & Uchitomi Y (1999) Algorithm for the treatment of major depression in patients with advanced cancer. Psychiatry and Clinical Neurosciences, 53 Suppl, S61-65.

PAGETOP


| HOME | 名市大精神医学教室 | 精神科専門研修を希望する方へ| 臨床について | 研究について | 教室内ニュース | Our Books |
©1999-2009 名古屋市立大学大学院 医学研究科 精神・認知・行動医学分野
〒467-8601 名古屋市瑞穂区瑞穂町字川澄1番地 Phone: 052-853-8271 FAx: 052-852-0837